The following discussion is designed to provide a better understanding of our
unaudited consolidated financial statements for the three months ended March 31,
2022, including a brief discussion of our business, key factors that impacted
our performance and a summary of our operating results. The following discussion
should be read in conjunction with the Unaudited Consolidated Financial
Statements and the notes thereto included in Item 1 of this Quarterly Report on
Form 10-Q, and the Consolidated Financial Statements and notes thereto and
Management's Discussion and Analysis of Financial Condition and Results of
Operations contained in our Annual Report on Form 10-K for the year ended
December 31, 2021. Historical results and percentage relationships among any
amounts in the financial statements are not necessarily indicative of trends in
operating results for any future periods.

Forward-Looking Statements



Some of the statements in this Quarterly Report constitute forward-looking
statements because they relate to future events or our future performance or
financial condition. Forward-looking statements may include, among other things,
statements as to our future operating results, our business prospects and the
prospects of our portfolio companies, the impact of the investments that we
expect to make, the ability of our portfolio companies to achieve their
objectives, our expected financings and investments, the adequacy of our cash
resources and working capital, and the timing of cash flows, if any, from the
operations of our portfolio companies. Words such as "expect," "anticipate,"
"target," "goals," "project," "intend," "plan," "believe," "seek," "estimate,"
"continue," "forecast," "may," "should," "potential," variations of such words,
and similar expressions indicate a forward-looking statement, although not all
forward-looking statements include these words. Readers are cautioned that the
forward-looking statements contained in this Quarterly Report are only
predictions, are not guarantees of future performance, and are subject to risks,
events, uncertainties and assumptions that are difficult to predict. Our actual
results could differ materially from those implied or expressed in the
forward-looking statements for any reason, including the items discussed herein,
in Item 1A entitled "Risk Factors" in Part I of our Annual Report on Form 10-K
for the year ended December 31, 2021 and in Item 1A entitled "Risk Factors" in
Part II of our subsequently filed Quarterly Reports on Form 10-Q. Other factors
that could cause our actual results and financial condition to differ materially
include, but are not limited to, changes in political, economic or industry
conditions, the interest rate environment or conditions affecting the financial
and capital markets, including with respect to changes from the impact of the
COVID-19 pandemic; the length and duration of the COVID-19 outbreak in the
United States as well as worldwide and the magnitude of the economic impact of
that outbreak; the effect of the COVID-19 pandemic on our business prospects and
the prospects of our portfolio companies, including our and their ability to
achieve our respective objectives; the effect of the disruptions caused by the
COVID-19 pandemic on our ability to continue to effectively manage our business
and on the availability of equity and debt capital and our use of borrowed money
to finance a portion of our investments; risks associated with possible
disruption due to terrorism in our operations or the economy generally; and
future changes in laws or regulations and conditions in our operating areas.
These statements are based on our current expectations, estimates, forecasts,
information and projections about the industry in which we operate and the
beliefs and assumptions of our management as of the date of filing of this
Quarterly Report. We assume no obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise, unless we are required to do so by law. Although we
undertake no obligation to revise or update any forward-looking statements,
whether as a result of new information, future events or otherwise, you are
advised to consult any additional disclosures that we may make directly to you
or through reports that we in the future may file with the SEC, including annual
reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form
8-K.

Overview of Our Business

We are a Maryland corporation incorporated on October 10, 2006. In August 2018,
in connection with the closing of an externalization transaction through which
Barings LLC ("Barings") agreed to become our external investment adviser, we
entered into an investment advisory agreement (the "Original Advisory
Agreement") and an administration agreement (the "Administration Agreement")
with Barings. In connection with the completion of our acquisition of MVC
Capital, Inc., a Delaware corporation, on December 23, 2020 (the "MVC
Acquisition"), we entered into an amended and restated investment advisory
agreement (the "Amended and Restated Advisory Agreement") with Barings on
December 23, 2020, following approval of the Amended and Restated Advisory
Agreement by our stockholders at our December 23, 2020 special meeting of
stockholders. The terms of the Amended and Restated Advisory Agreement became
effective on January 1, 2021. In connection with the completion of the Sierra
Acquisition (as defined below), on February 25, 2022, we entered into a second
amended and restated investment advisory agreement (the "New Barings BDC
Advisory Agreement") with the Adviser. Under the terms of the New Barings BDC
Advisory Agreement and the Administration Agreement, Barings serves as our
investment adviser and administrator and manages our investment portfolio and
performs (or oversees, or arranges for, the performance of) the administrative
services necessary for our operation.
                                       90
--------------------------------------------------------------------------------

An externally-managed BDC generally does not have any employees, and its
investment and management functions are provided by an outside investment
adviser and administrator under an advisory agreement and administration
agreement. Instead of directly compensating employees, we pay Barings for
investment management and administrative services pursuant to the terms of an
investment advisory agreement and an administration agreement. Under the terms
of the New Barings BDC Advisory Agreement, the fees paid to Barings for managing
our affairs are determined based upon an objective and fixed formula, as
compared with the subjective and variable nature of the costs associated with
employing management and employees in an internally-managed BDC structure, which
include bonuses that cannot be directly tied to Company performance because of
restrictions on incentive compensation under the Investment Company Act of 1940,
as amended (the "1940 Act").

Beginning in August 2018, Barings shifted our investment focus to invest in
syndicated senior secured loans, bonds and other fixed income securities. Since
that time, Barings has transitioned our portfolio to primarily senior secured
private debt investments in well-established middle-market businesses that
operate across a wide range of industries. Barings' existing SEC co-investment
exemptive relief under the 1940 Act (the "Exemptive Relief") permits us and
Barings' affiliated private and SEC-registered funds to co-invest in
Barings-originated loans, which allows Barings to efficiently implement its
senior secured private debt investment strategy for us.

Barings employs fundamental credit analysis, and targets investments in
businesses with relatively low levels of cyclicality and operating risk. The
holding size of each position will generally be dependent upon a number of
factors including total facility size, pricing and structure, and the number of
other lenders in the facility. Barings has experience managing levered vehicles,
both public and private, and will seek to enhance our returns through the use of
leverage with a prudent approach that prioritizes capital preservation. Barings
believes this strategy and approach offers attractive risk/return with lower
volatility given the potential for fewer defaults and greater resilience through
market cycles. A significant portion of our investments are expected to be rated
below investment grade by rating agencies or, if unrated would be rated below
investment grade if they were rated. Below investment grade securities, which
are often referred to as "junk," have predominantly speculative characteristics
with respect to the issuer's capacity to pay interest and repay principal.

We generate revenues in the form of interest income, primarily from our
investments in debt securities, loan origination and other fees and dividend
income. Fees generated in connection with our debt investments are recognized
over the life of the loan using the effective interest method or, in some cases,
recognized as earned. Our senior secured, middle-market, private debt
investments generally have terms of between five and seven years. Our senior
secured, middle-market, first lien private debt investments generally bear
interest between LIBOR (or the applicable currency rate for investments in
foreign currencies) plus 450 basis points and LIBOR plus 650 basis points per
annum. Our subordinated middle-market, private debt investments generally bear
interest between LIBOR (or the applicable currency rate for investments in
foreign currencies) plus 700 basis points and LIBOR plus 900 basis points per
annum if floating rate, and between 8% and 15% if fixed rate. From time to time,
certain of our investments may have a form of interest, referred to as
payment-in-kind, or PIK, interest, which is not paid currently but is instead
accrued and added to the loan balance and paid at the end of the term.

As of March 31, 2022 and December 31, 2021, the weighted average yield on the
principal amount of our outstanding debt investments other than non-accrual debt
investments was approximately 7.3% and 7.2%, respectively. The weighted average
yield on the principal amount of all of our outstanding debt investments
(including non-accrual debt investments) was approximately 6.8% and 6.9% as of
March 31, 2022 and December 31, 2021, respectively.

Sierra Income Corporation Acquisition



On February 25, 2022, we completed our acquisition of Sierra Income Corporation,
a Maryland corporation ("Sierra"), pursuant to the terms and conditions of that
certain Agreement and Plan of Merger (the "Sierra Merger Agreement"), dated as
of September 21, 2021, with Sierra, Mercury Acquisition Sub, Inc., a Maryland
corporation and our direct wholly owned subsidiary ("Sierra Acquisition Sub"),
and Barings. To effect the acquisition, Sierra Acquisition Sub merged with and
into Sierra, with Sierra surviving the merger as our wholly owned subsidiary
(the "First Sierra Merger"). Immediately thereafter, Sierra merged with and into
us, with Barings BDC, Inc. as the surviving company (the "Second Sierra Merger"
and, together with the First Sierra Merger, the "Sierra Merger").

Pursuant to the Sierra Merger Agreement, each share of Sierra common stock, par
value $0.001 per share (the "Sierra Common Stock"), issued and outstanding
immediately prior to the effective time of the First Sierra Merger (other than
shares of Sierra Common Stock issued and outstanding immediately prior to the
effective time of the First Sierra Merger that were held by a subsidiary of
Sierra or held, directly or indirectly, by us or Sierra Acquisition Sub) was
converted into the right to receive (i) an amount in cash from Barings, without
interest, equal to $0.9783641, and (ii) 0.44973 shares of the our common stock,
plus any cash in lieu of fractional shares. As a result of the Sierra Merger,
former Sierra stockholders received approximately 46.0 million shares of our
common stock for their shares of Sierra Common Stock.
                                       91
--------------------------------------------------------------------------------

In connection with the Sierra Acquisition, on February 25, 2022, following the
closing of the Sierra Merger, we entered into (1) the New Barings BDC Advisory
Agreement, and (2) a credit support agreement (the "Sierra Credit Support
Agreement") with Barings, pursuant to which Barings has agreed to provide credit
support to us in the amount of up to $100.0 million relating to the net
cumulative realized and unrealized losses on the acquired Sierra investment
portfolio over a 10-year period. See "Note 2. Agreements and Related Party
Transactions" and "Note. 6 Derivative Instruments" in the Notes to our
Consolidated Financial Statements included in this Quarterly Report on Form 10-Q
for more information.

In addition, in connection with the closing of the Sierra Merger, our board of
directors (the "Board") affirmed our commitment to purchase in open-market
transactions, pursuant to Rule 10b-18 under the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), and subject to our compliance with our covenant
and regulatory requirements, shares of our common stock in an aggregate amount
of up to $30,000,000 at then-current market prices at any time the shares of our
common stock trade below 90% of our then most recently disclosed net asset value
per share during the 12-month period commencing on April 1, 2022.

COVID-19 Developments



The spread of the Coronavirus and the COVID-19 pandemic, and the related effect
on the U.S. and global economies, has had adverse consequences for the business
operations of some of our portfolio companies and has adversely affected, and
threatens to continue to adversely affect, our operations and the operations of
Barings, including with respect to us. Barings has taken proactive steps around
COVID-19 to address the potential impacts on their people, clients, communities
and everyone they come in contact with, directly or through their premises.
Protecting their employees and supporting the communities in which they live and
work is a priority. Barings has now adopted a hybrid working model globally
while maintaining service levels to our partners and clients. Barings'
return-to-office taskforce continues to monitor the COVID-19 situation globally
and is prepared to adapt office working patterns as required to ensure the
safety of its employees and clients who visit Barings office locations. Barings'
cybersecurity policies are applied consistently when working remotely or in the
office.

While we have been carefully monitoring the COVID-19 pandemic and its impact on
our business and the business of our portfolio companies, we have continued to
fund our existing debt commitments. In addition, we have continued to make and
originate, and expect to continue to make and originate, new loans.

We cannot predict the full impact of the COVID-19 pandemic, including its
duration in the United States and worldwide and the magnitude of the economic
impact of the outbreak, including with respect to the travel restrictions,
business closures and other quarantine measures imposed on service providers and
other individuals by various local, state, and federal governmental authorities,
as well as non-U.S. governmental authorities. We are unable to predict the
extent and duration of any business and supply-chain disruptions, the extent to
which COVID-19 will negatively affect our portfolio companies' operating results
or the impact that such disruptions may have on our results of operations and
financial condition. Depending on the duration and extent of the disruption to
the operations of our portfolio companies, certain portfolio companies could
experience financial distress and possibly default on their financial
obligations to us and their other capital providers. Some of our portfolio
companies may significantly curtail business operations, furlough or lay off
employees and terminate service providers, and defer capital expenditures if
subjected to prolonged and severe financial distress, which would likely impair
their business on a permanent basis. These developments would likely result in a
decrease in the value of our investment in any such portfolio company.

We will continue to monitor the situation relating to the COVID-19 pandemic and
guidance from U.S. and international authorities, including federal, state and
local public health authorities and may take additional actions based on their
recommendations. In these circumstances, there may be developments outside our
control requiring us to adjust our plan of operation. As such, given the dynamic
nature of this situation, we cannot reasonably estimate the impacts of COVID-19
on our financial condition, results of operations or cash flows in the future.
However, to the extent our portfolio companies are adversely impacted by the
effects of the COVID-19 pandemic, it may have a material adverse impact on our
future net investment income, the fair value of our portfolio investments, our
financial condition and the results of operations and financial condition of our
portfolio companies.
                                       92
--------------------------------------------------------------------------------

Relationship with Our Adviser, Barings



Our investment adviser, Barings, a wholly-owned subsidiary of Massachusetts
Mutual Life Insurance Company, is a leading global asset management firm and is
registered with the SEC as an investment adviser under the Investment Advisers
Act of 1940, as amended. Barings' primary investment capabilities include fixed
income, private credit, real estate, equity, and alternative investments.
Subject to the overall supervision of the Board, Barings' Global Private Finance
Group ("BGPF") manages our day-to-day operations, and provides investment
advisory and management services to us. BGPF is part of Barings' $290.9 billion
Global Fixed Income Platform that invests in liquid, private and structured
credit. BGPF manages private funds and separately managed accounts, along with
multiple public vehicles.

Among other things, Barings (i) determines the composition of our portfolio, the
nature and timing of the changes therein and the manner of implementing such
changes; (ii) identifies, evaluates and negotiates the structure of the
investments made by us; (iii) executes, closes, services and monitors the
investments that we make; (iv) determines the securities and other assets that
we will purchase, retain or sell; (v) performs due diligence on prospective
portfolio companies and (vi) provides us with such other investment advisory,
research and related services as we may, from time to time, reasonably require
for the investment of our funds.

Under the terms of the Administration Agreement, Barings performs (or oversees,
or arranges for, the performance of) the administrative services necessary for
our operation, including, but not limited to, office facilities, equipment,
clerical, bookkeeping and record keeping services at such office facilities and
such other services as Barings, subject to review by the Board, will from time
to time determine to be necessary or useful to perform its obligations under the
Administration Agreement. Barings also, on our behalf and subject to the Board's
oversight, arranges for the services of, and oversees, custodians, depositories,
transfer agents, dividend disbursing agents, other stockholder servicing agents,
accountants, attorneys, underwriters, brokers and dealers, corporate
fiduciaries, insurers, banks and such other persons in any such other capacity
deemed to be necessary or desirable. Barings is responsible for the financial
and other records that we are required to maintain and will prepare all reports
and other materials required to be filed with the SEC or any other regulatory
authority.

Stockholder Approval of Reduced Asset Coverage Ratio



On July 24, 2018, our stockholders voted at a special meeting of stockholders
(the "2018 Special Meeting") to approve a proposal to authorize us to be subject
to a reduced asset coverage ratio of at least 150% under the 1940 Act. As a
result of the stockholder approval at the 2018 Special Meeting, effective July
25, 2018, our applicable asset coverage ratio under the 1940 Act has been
decreased to 150% from 200%. As a result, we are permitted under the 1940 Act to
incur indebtedness at a level which is more consistent with a portfolio of
senior secured debt. As of March 31, 2022, our asset coverage ratio was 188.9%.

Portfolio Investment Composition



The total value of our investment portfolio was $2,403.4 million as of March 31,
2022, as compared to $1,800.6 million as of December 31, 2021. As of March 31,
2022, we had investments in 287 portfolio companies with an aggregate cost of
$2,391.6 million. As of December 31, 2021, we had investments in 212 portfolio
companies with an aggregate cost of $1,787.8 million. As of both March 31, 2022
and December 31, 2021, none of our portfolio investments represented greater
than 10% of the total fair value of our investment portfolio.
                                       93
--------------------------------------------------------------------------------

As of March 31, 2022 and December 31, 2021, our investment portfolio consisted of the following investments:


                                                                  Percentage of                                       Percentage of
                                                                      Total                                               Total
($ in thousands)                             Cost                   Portfolio                 Fair Value                Portfolio
March 31, 2022:
Senior debt and 1st lien notes          $ 1,560,223                             65  %       $ 1,555,746                             65  %
Subordinated debt and 2nd lien notes        346,381                             14              317,643                             13
Structured products                          84,056                              4               82,014                              3
Equity shares                               170,691                              7              219,466                              9
Equity warrants                                 174                              -                  156                              -
Investment in joint ventures / PE fund      230,076                             10              228,400                             10

                                        $ 2,391,601                            100  %       $ 2,403,425                            100  %
December 31, 2021:
Senior debt and 1st lien notes          $ 1,217,899                             68  %       $ 1,221,598                             68  %
Subordinated debt and 2nd lien notes        253,551                             14              240,037                             13
Structured products                          37,055                              2               40,271                              2
Equity shares                               145,791                              8              154,477                              9
Equity warrants                               1,111                              -                1,107                              -
Investment in joint ventures / PE fund      132,417                              8              143,104                              8

                                        $ 1,787,824                            100  %       $ 1,800,594                            100  %

Investment Activity



During the three months ended March 31, 2022, we made 22 new investments
totaling $229.3 million, purchased $442.2 million of investments as part of the
Sierra Acquisition, made investments in existing portfolio companies totaling
$89.3 million and made additional investments in joint venture equity portfolio
companies totaling $11.7 million. We had four loans repaid totaling $12.4
million and received $7.5 million of portfolio company principal payments. In
addition, we sold $19.2 million of loans, recognizing a net realized gain on
these transactions of $0.8 million, and sold $132.3 million of middle-market
portfolio company debt investments to one of our joint ventures and realized a
loss on these transactions of $0.2 million. Lastly, we received proceeds related
to the sale of equity investments totaling $1.6 million and recognized a net
realized loss on such sales totaling $0.7 million.

During the three months ended March 31, 2021, we made 18 new investments
totaling $172.2 million, made investments in existing portfolio companies
totaling $73.2 million, made one new investment in a joint venture equity
portfolio company totaling $4.5 million and made additional investments in
existing joint venture equity portfolio companies totaling $25.0 million. We had
six loans repaid at par totaling $26.2 million and received $6.0 million of
portfolio company principal payments. In addition, we sold $57.1 million of
loans, recognizing a net realized gain on these transactions of $2.4 million,
and sold $94.7 million of middle-market portfolio company debt investments to
one of our joint ventures and realized a gain on these transactions of $0.5
million. Lastly, we received proceeds related to the sale of an equity
investment totaling $5.9 million and recognized a net realized loss on such sale
totaling $0.1 million.
                                       94
--------------------------------------------------------------------------------

Total portfolio investment activity for the three months ended March 31, 2022
and 2021 was as follows:
Three Months Ended                Senior Debt                                                                                                Investments in
March 31, 2022:                  and 1st Lien         Subordinated Debt          Structured             Equity             Equity           Joint Ventures /
($ in thousands)                     Notes            and 2nd Lien Notes          Products              Shares            Warrants              PE Fund                       Total

Fair value, beginning of period $ 1,221,598 $ 240,037

   $     40,271          $ 154,477          $   1,107          $       143,104                $ 1,800,594
New investments                      268,202                   30,065                 1,060             19,200                  -                   11,696                    330,223
Investments acquired in Sierra
merger                               235,770                   66,662                46,666              7,065                 72                   85,963                    442,198
Proceeds from sales of
investments                         (151,575)                       -                     -             (1,388)              (249)                       -                   (153,212)
Loan origination fees received        (5,350)                      36                     -                  -                  -                        -                     (5,314)
Principal repayments received         (8,114)                 (11,020)                 (730)                 -                  -                        -                    (19,864)
Payment-in-kind interest               1,050                    6,984                                        -                  -                        -                         8,034
Accretion of loan
premium/discount                         301                       33                     5                  -                  -                        -                        339
Accretion of deferred loan
origination revenue                    1,461                       62                     -                  -                  -                        -                      1,523
Realized gain (loss)                        579                        8                     -                 24              (760)                        -                    (149)
Unrealized appreciation
(depreciation)                          (8,176)                 (15,224)               (5,258)             40,088               (14)                 (12,363)                    (947)

Fair value, end of period $ 1,555,746 $ 317,643

   $     82,014          $ 219,466          $     156          $       228,400                $ 2,403,425



Three Months Ended              Senior Debt                                                                                               Investments in
March 31, 2021:                and 1st Lien         Subordinated Debt          Structured            Equity             Equity           Joint Ventures /          Short-term
($ in thousands)                   Notes            and 2nd Lien Notes          Products             Shares            Warrants              PE Fund               Investments             Total
Fair value, beginning of
period                        $  1,171,250          $       138,767

$ 32,509 $ 44,651 $ 1,300 $ 41,760

$     65,558          $ 1,495,795
New investments                    227,057                   14,479                     -             3,873                  -                   29,500               198,550              473,459
Proceeds from sales of
investments                       (144,893)                       -                (6,823)           (5,972)                 -                        -              (190,542)            (348,230)
Loan origination fees
received                            (4,176)                    (402)                    -                 -                  -                        -                     -               (4,578)
Principal repayments received      (21,392)                 (10,120)                 (753)                -                  -                        -                     -              (32,265)
Payment-in-kind interest               829                    7,007                     -                 -                  -                        -                     -                   7,836
Accretion of loan
premium/discount                       645                    1,319                    16                 -                  -                        -                     -                1,980
Accretion of deferred loan
origination revenue                  1,270                      211                     -                 -                  -                        -                     -                1,481
Realized gain (loss)                    2,207                        3                   652              (51)                  -                        -                     3             2,814
Unrealized appreciation
(depreciation)                          5,381                    (666)                   553           (2,883)                134                    1,316                   (3)             3,832

Fair value, end of period $ 1,238,178 $ 150,598

 $     26,154          $ 39,618          $   1,434          $        72,576          $     73,566          $ 1,602,124


Non-Accrual Assets

Generally, when interest and/or principal payments on a loan become past due, or
if we otherwise do not expect the borrower to be able to service its debt and
other obligations, we will place the loan on non-accrual status and will
generally cease recognizing interest income on that loan for financial reporting
purposes until all principal and interest have been brought current through
payment or due to a restructuring such that the interest income is deemed to be
collectible. As of March 31, 2022, we had seven portfolio companies with
investments on non-accrual, the fair value of which was $42.9 million, which
comprised 1.8% of the total fair value of our portfolio, and the cost of which
was $71.3 million, which comprised 3.0% of the total cost of our portfolio. As
of December 31, 2021, we had two portfolio companies with investments on
non-accrual, the fair value of which was $36.0 million, which comprised 2.0% of
the total fair value of our portfolio, and the cost of which was $50.9 million,
which comprised 2.9% of the total cost of our portfolio.
                                       95
--------------------------------------------------------------------------------

A summary of our non-accrual assets as of March 31, 2022 is provided below:

1888 Industrial Services, LLC



In connection with the Sierra Acquisition, we purchased our debt and equity
investments in 1888 Industrial Services, LLC, or 1888. The 1888 first lien
senior secured term loan is on non-accrual status and as a result, under U.S.
GAAP, we will not recognize interest income on our first lien senior secured
term loan in 1888 for financial reporting purposes. As of March 31, 2022, the
cost and fair of our first lien senior secured term loan in 1888 was $0.4
million and $0.2 million, respectively.

Black Angus Steakhouse, LLC



In connection with the Sierra Acquisition, we purchased our debt and equity
investments in Black Angus Steakhouse, LLC, or Black Angus. The Black Angus PIK
term loan is on non-accrual status and as a result, under U.S. GAAP, we will not
recognize interest income on our PIK term loan in Black Angus for financial
reporting purposes. As of March 31, 2022, both the cost and fair value of our
PIK term loan in Black Angus was $9.6 million.

Charming Charlie LLC



In connection with the Sierra Acquisition, we purchased our debt and equity
investments in Charming Charlie, LLC, or Charming Charlie. Charming Charlie is
on non-accrual status and as a result, under U.S. GAAP, we will not recognize
interest income on our debt investments in Charming Charlie for financial
reporting purposes. As of March 31, 2022, both the cost and fair value of our
debt investments in Charming Charlie was zero.

Custom Alloy Corporation



In connection with the MVC Acquisition, we purchased our debt investment in
Custom Alloy Corporation, or Custom Alloy. During the quarter ended December 31,
2021, we placed our debt investment in Custom Alloy on non-accrual status. As a
result, under U.S. GAAP, we will not recognize interest income on our debt
investment in Custom Alloy for financial reporting purposes. As of March 31,
2022, the cost of our debt investment in Custom Alloy was $46.4 million and the
fair value of such investment was $28.6 million.

Holland Acquisition Corp.



In connection with the Sierra Acquisition, we purchased our debt investment in
Holland Acquisition Corp., or Holland. Holland is on non-accrual status and as a
result, under U.S. GAAP, we will not recognize interest income on our debt
investments in Holland for financial reporting purposes. As of March 31, 2022,
both the cost and fair value of our debt investments in Holland was zero.

Legal Solutions Holdings



In connection with the MVC Acquisition, we purchased our debt investment in
Legal Solutions Holdings, or Legal Solutions. During the quarter ended September
30, 2021, we placed our debt investment in Legal Solutions on non-accrual
status. As a result, under U.S. GAAP, we will not recognize interest income on
our debt investment in Legal Solutions for financial reporting purposes. As of
March 31, 2022, the cost of our debt investment in Legal Solutions was $10.1
million and the fair value of such investment was zero.

Path Medical LLC



In connection with the Sierra Acquisition, we purchased our debt and equity
investments in Path Medical LLC, or Path Medical. Path Medical is on non-accrual
status and as a result, under U.S. GAAP, we will not recognize interest income
on our debt investments in Path Medical for financial reporting purposes. As of
March 31, 2022, both the cost and fair value of our debt investments in Path
Medical was $4.6 million.


                                       96

--------------------------------------------------------------------------------

Results of Operations

Comparison of the three months ended March 31, 2022 and March 31, 2021



Operating results for the three months ended March 31, 2022 and 2021 were as
follows:
                                                                       Three Months           Three Months
                                                                          Ended                  Ended
                                                                        March 31,              March 31,
(in thousands)                                                             2022                   2021

Total investment income                                              $      43,757          $      30,593

Total operating expenses                                                    24,742                 16,237
Net investment income before taxes                                          19,015                 14,356
Income taxes, including excise tax provision                                     6                    (18)
Net investment income after taxes                                           19,009                 14,374

Net realized gains (losses)                                                 (1,442)                 1,839

Net unrealized appreciation                                                  3,465                  6,275

Net increase in net assets resulting from operations                 $      

21,032 $ 22,488

Net increases or decreases in net assets resulting from operations can vary substantially from period to period due to various factors, including recognition of realized gains and losses and unrealized appreciation and depreciation. As a result, quarterly comparisons of net changes in net assets resulting from operations may not be meaningful.



Investment Income

                                           Three Months       Three Months
                                               Ended              Ended
                                             March 31,          March 31,
($ in thousands)                               2022               2021
Investment income:

Total interest income                     $      32,069      $      25,214

Total dividend income                             7,693                 72

Total fee and other income                        1,197              2,133

Total payment-in-kind interest income             2,798              3,173
Interest income from cash                             -                  1
Total investment income                   $      43,757      $      30,593


The change in total investment income for the three months ended March 31, 2022,
as compared to the three months ended March 31, 2021, was primarily due to an
increase in the average size of our portfolio and increased dividends from
portfolio companies and joint venture investments. The increase in the average
size of our portfolio was largely due to the increased middle-market investment
opportunities and the investments acquired as part of the Sierra Acquisition;
however, as the Sierra Acquisition did not close until late in the first quarter
of 2022, we did not receive a full quarter of investment income from the
acquired Sierra portfolio. This increase was partial offset by a decrease in
payment-in-kind ("PIK") interest income and a decrease in acceleration of
unamortized OID and unamortized loan origination fee income associated with
repayments of loans. For the three months ended March 31, 2022, dividends from
portfolio companies and joint venture investments were $7.7 million, as compared
to $0.1 million for the three months ended March 31, 2021. The amount of our
outstanding debt investments was $2,134.2 million as of March 31, 2022, as
compared to $1,451.9 million as of March 31, 2021. This increase is in part due
to the acquisition of investment assets in the Sierra Acquisition. The weighted
average yield on the principal amount of our outstanding debt investments other
than non-accrual debt investments was 7.3% as of March 31, 2022, as compared to
7.2% as of March 31, 2021. For the three months ended March 31, 2022, PIK
interest income was $2.8 million, as compared to $3.2 million for the three
months ended March 31, 2021. For the three months ended March 31, 2022,
acceleration of unamortized OID income and unamortized loan origination fees
totaled $0.2 million, as compared to $0.4 million for the three months ended
March 31, 2021.

Operating Expenses
                                                Three Months       Three Months
                                                    Ended              Ended
                                                  March 31,          March 31,
         ($ in thousands)                           2022               2021

         Operating expenses:
         Interest and other financing fees     $      11,661      $       7,285
         Base management fees                          5,872              3,929
         Incentive management fees                     4,754              2,722

         General and administrative expenses           2,455              2,301
         Total operating expenses              $      24,742      $      16,237


                                       97

--------------------------------------------------------------------------------

Interest and Other Financing Fees



Interest and other financing fees during the three months ended March 31, 2022
were attributable to borrowings under the February 2019 Credit Facility, the
August 2025 Notes, the November Notes, the February Notes and the November 2026
Notes (each as defined below under "Liquidity and Capital Resources"). Interest
and other financing fees during the three months ended March 31, 2021 were
attributable to borrowings under the February 2019 Credit Facility, the August
2025 Notes, the November Notes and the February Notes. The increase in interest
and other financing fees for the three months ended March 31, 2022 as compared
to the three months ended March 31, 2021, was primarily attributable to the
issuance of the February Notes and the November 2026 Notes and increased
borrowings under the February 2019 Credit Facility.

Base Management Fees



Under the terms of the New Barings BDC Advisory Agreement, we pay Barings a base
management fee (the "Base Management Fee"), quarterly in arrears on a calendar
quarter basis. The Base Management Fee is calculated based on the average value
of our gross assets, excluding cash and cash equivalents, at the end of the two
most recently completed calendar quarters prior to the quarter for which such
fees are being calculated. Base Management Fees for any partial month or quarter
are appropriately pro-rated. See Note 2 to our Unaudited Consolidated Financial
Statements for additional information regarding the terms of the New Barings BDC
Advisory Agreement (and, from January 1, 2021 to February 25, 2022, the terms of
the Amended and Restated Advisory Agreement) and the fee arrangements
thereunder. For the three months ended March 31, 2022, the amount of Base
Management Fee incurred was approximately $5.9 million. For the three months
ended March 31, 2021, the amount of Base Management Fee incurred was
approximately $3.9 million. The increase in the Base Management Fee for the
three months ended March 31, 2022 versus the corresponding 2021 period is
primarily related to the average value of gross assets increasing from $1,257.4
million as of the end of the two most recently completed calendar quarters prior
to March 31, 2021 to $1,879.0 million as of the end of the two most recently
completed calendar quarters prior to March 31, 2022. For both the three months
ended March 31, 2022 and 2021, the Base Management Fee rate was 1.250%.

Incentive Fee



Under the New Barings BDC Advisory Agreement (and, from January 1, 2021 to
February 25, 2022, pursuant to the terms of the Amended and Restated Advisory
Agreement), we pay Barings an incentive fee. A portion of the incentive fee is
based on our income and a portion is based on our capital gains. The
income-based fee will be determined and paid quarterly in arrears based on the
amount by which (x) the aggregate pre-incentive fee net investment income in
respect of the current calendar quarter and the eleven preceding calendar
quarters beginning with the calendar quarter that commences on or after January
1, 2021, as the case may be (or the appropriate portion thereof in the case of
any of our first eleven calendar quarters that commences on or after January 1,
2021) exceeds (y) the hurdle amount as calculated for the same period. See Note
2 to our Unaudited Consolidated Financial Statements for additional information
regarding the terms of the New Barings BDC Advisory Agreement and the fee
arrangements thereunder. For the three months ended March 31, 2022, the amount
of income-based fee incurred was $4.8 million, as compared to $2.7 million for
the three months ended March 31, 2021.

General and Administrative Expenses



We entered into the Administration Agreement with Barings in August 2018. Under
the terms of the Administration Agreement, Barings performs (or oversees, or
arranges for, the performance of) the administrative services necessary for our
operations. We will reimburse Barings for the costs and expenses incurred by it
in performing its obligations and providing personnel and facilities under the
Administration Agreement in an amount to be negotiated and mutually agreed to by
us and Barings quarterly in arrears; provided that the agreed-upon quarterly
expense amount will not exceed the amount of expenses that would otherwise be
reimbursable by us under the Administration Agreement for the applicable
quarterly period, and Barings will not be entitled to the recoupment of any
amounts in excess of the agreed-upon quarterly expense amount. See Note 2 to our
Unaudited Consolidated Financial Statements for additional information regarding
the Administration Agreement. For the three months ended March 31, 2022, the
amount of administration expense incurred and invoiced by Barings for expenses
was approximately $1.0 million. For the three months ended March 31, 2021, the
amount of administration expense incurred and invoiced by Barings for expenses
was approximately $0.5 million. In addition to expenses incurred under the
Administration Agreement, general and administrative expenses include Board
fees, D&O insurance costs, as well as legal, valuation and accounting expenses.
                                       98
--------------------------------------------------------------------------------

Net Realized Gains (Losses)



Net realized gains (losses) during the three months ended March 31, 2022 and
2021 were as follows:
                                                    Three Months       Three Months
                                                        Ended              Ended
                                                      March 31,          March 31,
      ($ in thousands)                                  2022               2021


      Net realized gain (losses):
      Non-Control / Non-Affiliate investments      $        (250)     $       2,891
      Affiliate investments                                  101                (77)

      Net realized gains (losses) on investments            (149)             2,814
      Foreign currency transactions                       (1,293)              (975)
      Net realized gains (losses)                  $      (1,442)     $       1,839


During the three months ended March 31, 2022, we recognized net realized losses
totaling $1.4 million, which consisted primarily of a net loss on foreign
currency transactions of $1.3 million. During the three months ended March 31,
2021, we recognized net realized gains totaling $1.8 million, which consisted
primarily of a net gain on our loan portfolio of $2.8 million partially offset
by a net loss on foreign currency transactions of $1.0 million.

Net Unrealized Appreciation (Depreciation)

Net unrealized appreciation (depreciation) during the three months ended March 31, 2022 and 2021 was as follows:


                                                                         Three Months           Three Months
                                                                            Ended                  Ended
                                                                          March 31,              March 31,
($ in thousands)                                                             2022                   2021

Net unrealized appreciation (depreciation):
Non-Control / Non-Affiliate investments                                $     (28,587)         $       5,357
Affiliate investments                                                         12,996                  2,445
Control investments                                                           14,644                 (3,969)
Net unrealized appreciation (depreciation) on investments                       (947)                 3,833
Credit support agreements                                                       (400)                (1,600)
Foreign currency transactions                                                  4,812                  4,042
Net unrealized appreciation                                            $    

3,465 $ 6,275




During the three months ended March 31, 2022, we recorded net unrealized
appreciation totaling $3.5 million, consisting of net unrealized appreciation on
our current portfolio of $0.1 million and net unrealized appreciation related to
foreign currency transactions of $4.8 million, net of unrealized depreciation of
$0.4 million on the MVC credit support agreement with Barings and net unrealized
depreciation reclassification adjustments of $1.0 million related to the net
realized gains on the sales / repayments of certain investments. The net
unrealized appreciation on our current portfolio of $0.1 million was driven
primarily by credit or fundamental performance of investments of $27.8 million,
partially offset by the impact of foreign currency exchange rates on investments
of $4.7 million and broad market moves for investments of $23.1 million.

During the three months ended March 31, 2021, we recorded net unrealized
appreciation totaling $6.3 million, consisting of net unrealized appreciation on
our current portfolio of $6.4 million and net unrealized appreciation related to
foreign currency transactions of $4.0 million, net of unrealized depreciation of
$1.6 million on the MVC credit support agreement with Barings and net of
unrealized depreciation reclassification adjustments of $2.6 million related to
the net realized gains on the sales / repayments of certain investments. The net
unrealized appreciation on our current portfolio of $6.4 million was driven
primarily by broad market moves for investments of $13.8 million, partially
offset by depreciation from the credit or fundamental performance of investments
of $3.0 million and the impact of foreign currency exchange rates on investments
of $4.4 million.

Liquidity and Capital Resources



We believe that our current cash and foreign currencies on hand, our available
borrowing capacity under the February 2019 Credit Facility and our anticipated
cash flows from operations will be adequate to meet our cash needs for our daily
operations for at least the next twelve months. This "Liquidity and Capital
Resources" section should be read in conjunction with "COVID-19 Developments"
above, as well as with the notes to our Unaudited Consolidated Financial
Statements.
                                       99
--------------------------------------------------------------------------------

Cash Flows



For the three months ended March 31, 2022, we experienced a net increase in cash
in the amount of $70.2 million. During that period, our operating activities
used $18.8 million in cash, consisting primarily of purchases of portfolio
investments of $335.5 million, partially offset by net cash acquired from the
acquisition of Sierra of $101.9 million and proceeds from sales or repayments of
portfolio investments totaling $210.5 million. In addition, our financing
activities provided net cash of $89.0 million, consisting of net borrowings
under the February 2019 Credit Facility (as defined below under "Financing
Transactions") of $107.7 million, partially offset by dividends paid in the
amount of $15.0 million and share repurchases of $2.1 million. As of March 31,
2022, we had $154.4 million of cash and foreign currencies on hand.

For the three months ended March 31, 2021, we experienced a net decrease in cash
in the amount of $52.0 million. During that period, our operating activities
used $85.1 million in cash, consisting primarily of purchases of portfolio
investments of $276.5 million and purchases of short-term investments of $198.6
million, partially offset by proceeds from sales of portfolio investments
totaling $188.2 million and sales of short-term investments of $190.5 million.
In addition, our financing activities provided $33.1 million of cash, consisting
of net proceeds of $149.8 million from the issuance of the February Notes,
partially offset by net repayments under the February 2019 Credit Facility of
$104.3 million and dividends paid in the amount of $12.4 million. As of
March 31, 2021, we had $40.5 million of cash and foreign currencies on hand.

Financing Transactions

February 2019 Credit Facility

On February 21, 2019, we entered into a senior secured credit facility with ING
Capital LLC ("ING"), as administrative agent, and the lenders party thereto (as
amended, restated and otherwise modified from time to time, the "February 2019
Credit Facility"). The initial commitments under the February 2019 Credit
Facility total $800.0 million. Effective on November 4, 2021, we increased
aggregate commitments under the February 2019 Credit Facility to $875.0 million
from $800.0 million pursuant to the accordion feature under the February 2019
Credit Facility, which allows for an increase in the total commitments to an
aggregate of $1.2 billion subject to certain conditions and the satisfaction of
specified financial covenants. Effective on February 25, 2022, we increased
aggregate commitments under the February 2019 Credit Facility to $965.0 million
from $875.0 million pursuant to the accordion feature under the February 2019
Credit Facility, and the allowance for an increase in the total commitments
increased to $1.5 billion from $1.2 billion subject to certain conditions and
the satisfaction of specified financial covenants. We can borrow foreign
currencies directly under the February 2019 Credit Facility. The February 2019
Credit Facility, which is structured as a revolving credit facility, is secured
primarily by a material portion of our assets and guaranteed by certain of our
subsidiaries. Following the termination on June 30, 2020 of Barings BDC Senior
Funding I, LLC's ("BSF") credit facility entered into in August 2018 with Bank
of America, N.A. (the "August 2018 Credit Facility"), BSF became a subsidiary
guarantor and its assets secure the February 2019 Credit Facility. The revolving
period of the February 2019 Credit Facility ends on February 21, 2024, followed
by a one-year repayment period with a maturity date of February 21, 2025.

Borrowings denominated in U.S. Dollars under the February 2019 Credit Facility
bear interest, subject to our election, on a per annum basis equal to (i) the
alternate base rate plus 1.25% (or 1.00% for so long as we maintain an
investment grade credit rating) or (ii) the term Secured Overnight Financing
Rate ("SOFR") plus 2.25% (or 2.00% for so long as we maintain an investment
grade credit rating) plus a credit spread adjustment of 0.10% for borrowings
with an interest period of one month, 0.15% for borrowings with an interest
period of three months or 0.25% for borrowings with an interest period of six
months. The alternate base rate is equal to the greatest of (i) the prime rate,
(ii) the federal funds rate plus 0.5%, (iii) the Overnight Bank Funding Rate
plus 0.5%, (iv) one-month term SOFR plus 1.0% plus a credit spread adjustment of
0.10% and (v) 1.0%. For borrowings denominated in certain foreign currencies
other than Australian dollars, the applicable currency rate for the foreign
currency as defined in the credit agreement plus 2.00% (or 2.25% if we no longer
maintain an investment grade credit rating) or for borrowings denominated in
Australian dollars, the applicable Australian dollars Screen Rate, plus 2.20%
(or 2.45% if we no longer maintain an investment grade credit rating).

In addition, we pay a commitment fee of (i) 0.5% per annum on undrawn amounts if
the unused portion of the February 2019 Credit Facility is greater than
two-thirds of total commitments or (ii) 0.375% per annum on undrawn amounts if
the unused portion of the February 2019 Credit Facility is equal to or less than
two-thirds of total commitments. In connection with entering into the February
2019 Credit Facility, we incurred financing fees of approximately $6.4 million,
which will be amortized over the life of the February 2019 Credit Facility.

As of March 31, 2022, we were in compliance with all covenants under the
February 2019 Credit Facility and had U.S. dollar borrowings of $472.0 million
outstanding under the February 2019 Credit Facility with an interest rate of
2.318% (one month SOFR of 0.218%), borrowings denominated in Swedish kronas of
12.8kr million ($1.4 million U.S. dollars) with an interest rate of 2.000% (one
month STIBOR of 0.000%), borrowings denominated in British pounds sterling of
£77.6 million
                                      100
--------------------------------------------------------------------------------

($102.1 million U.S. dollars) with an interest rate of 2.477% (one month SONIA
of 0.477%), borrowings denominated in Australian dollars of A$36.6 million
($27.5 million U.S. dollars) with an interest rate of 2.250% (one month AUD
Screen Rate of 0.250%) and borrowings denominated in Euros of €138.6 million
($154.2 million U.S. dollars) with an interest rate of 2.000% (one month EURIBOR
of 0.000%). The borrowings denominated in foreign currencies were translated
into U.S. dollars based on the spot rate at the relevant balance sheet date. The
impact resulting from changes in foreign exchange rates on the February 2019
Credit Facility borrowings is included in "Net unrealized appreciation
(depreciation) - foreign currency transactions" in our Unaudited Consolidated
Statements of Operations.

The fair values of the borrowings outstanding under the February 2019 Credit
Facility are based on a market yield approach and current interest rates, which
are Level 3 inputs to the market yield model. As of March 31, 2022, the total
fair value of the borrowings outstanding under the February 2019 Credit Facility
was $757.2 million. See Note 5 to our Unaudited Consolidated Financial
Statements for additional information regarding the February 2019 Credit
Facility.

August 2025 Notes



On August 3, 2020, we entered into a Note Purchase Agreement (the "August 2020
NPA") with Massachusetts Mutual Life Insurance Company governing the issuance of
(1) $50.0 million in aggregate principal amount of Series A senior unsecured
notes due August 2025 (the "Series A Notes due 2025") with a fixed interest rate
of 4.66% per year, and (2) up to $50.0 million in aggregate principal amount of
additional senior unsecured notes due August 2025 with a fixed interest rate per
year to be determined (the "Additional Notes" and, collectively with the Series
A Notes due 2025, the "August 2025 Notes"), in each case, to qualified
institutional investors in a private placement. An aggregate principal amount of
$25.0 million of the Series A Notes due 2025 was issued on September 24, 2020
and an aggregate principal amount of $25.0 million of the Series A Notes due
2025 was issued on September 29, 2020, both of which will mature on August 4,
2025 unless redeemed, purchased or prepaid prior to such date by us in
accordance with their terms. Interest on the August 2025 Notes is due
semiannually in March and September, beginning in March 2021. In addition, we
are obligated to offer to repay the August 2025 Notes at par (plus accrued and
unpaid interest to, but not including, the date of prepayment) if certain change
in control events occur. Subject to the terms of the August 2020 NPA, we may
redeem the August 2025 Notes in whole or in part at any time or from time to
time at our option at par plus accrued interest to the prepayment date and, if
redeemed on or before November 3, 2024, a make-whole premium. The August 2025
Notes are guaranteed by certain of our subsidiaries, and are our general
unsecured obligations that rank pari passu with all outstanding and future
unsecured unsubordinated indebtedness issued by us.

On November 4, 2020, we amended the August 2020 NPA to reduce the aggregate principal amount of unissued Additional Notes from $50.0 million to $25.0 million.



The August 2020 NPA contains certain representations and warranties, and various
covenants and reporting requirements customary for senior unsecured notes issued
in a private placement, including, without limitation, affirmative and negative
covenants such as information reporting, maintenance of our status as a BDC
within the meaning of the 1940 Act, certain restrictions with respect to
transactions with affiliates, fundamental changes, changes of line of business,
permitted liens, investments and restricted payments, minimum shareholders'
equity, maximum net debt to equity ratio and minimum asset coverage ratio. The
August 2020 NPA also contains customary events of default with customary cure
and notice periods, including, without limitation, nonpayment, incorrect
representation in any material respect, breach of covenant, cross-default under
our other indebtedness or that of our subsidiary guarantors, certain judgements
and orders, and certain events of bankruptcy. Upon the occurrence of an event of
default, the holders of at least 66-2/3% in principal amount of the August 2025
Notes at the time outstanding may declare all August 2025 Notes then outstanding
to be immediately due and payable. As of March 31, 2022, we were in compliance
with all covenants under the August 2020 NPA.

The August 2025 Notes were offered in reliance on Section 4(a)(2) of the
Securities Act of 1933, as amended (the "Securities Act"). The August 2025 Notes
have not and will not be registered under the Securities Act or any state
securities laws and, unless so registered, may not be offered or sold in the
United States except pursuant to an exemption from, or in a transaction not
subject to, the registration requirements of the Securities Act, as applicable.

As of March 31, 2022, the fair value of the outstanding August 2025 Notes was
$49.7 million. The fair value determination of the August 2025 Notes was based
on a market yield approach and current interest rates, which are Level 3 inputs
to the market yield model.

November Notes

On November 4, 2020, we entered into a Note Purchase Agreement (the "November
2020 NPA") governing the issuance of (1) $62.5 million in aggregate principal
amount of Series B senior unsecured notes due November 2025 (the "Series B
Notes") with a fixed interest rate of 4.25% per year and (2) $112.5 million in
aggregate principal amount of Series C senior
                                      101
--------------------------------------------------------------------------------

unsecured notes due November 2027 (the "Series C Notes," and, collectively with
the Series B Notes, the "November Notes") with a fixed interest rate of 4.75%
per year, in each case, to qualified institutional investors in a private
placement. Each stated interest rate is subject to a step up of (x) 0.75% per
year, to the extent the applicable November Notes do not satisfy certain
investment grade conditions and/or (y) 1.50% per year, to the extent the ratio
of our secured debt to total assets exceeds specified thresholds, measured as of
each fiscal quarter end. The November Notes were delivered and paid for on
November 5, 2020.

The Series B Notes will mature on November 4, 2025, and the Series C Notes will
mature on November 4, 2027 unless redeemed, purchased or prepaid prior to such
date by us in accordance with their terms. Interest on the November Notes is due
semiannually in May and November, beginning in May 2021. In addition, we are
obligated to offer to repay the November Notes at par (plus accrued and unpaid
interest to, but not including, the date of prepayment) if certain change in
control events occur. Subject to the terms of the November 2020 NPA, we may
redeem the Series B Notes and the Series C Notes in whole or in part at any time
or from time to time at our option at par plus accrued interest to the
prepayment date and, if redeemed on or before May 4, 2025, with respect to the
Series B Notes, or on or before May 4, 2027, with respect to the Series C Notes,
a make-whole premium. The November Notes are guaranteed by certain of our
subsidiaries, and are our general unsecured obligations that rank pari passu
with all outstanding and future unsecured unsubordinated indebtedness issued by
us.

The November 2020 NPA contains certain representations and warranties, and
various covenants and reporting requirements customary for senior unsecured
notes issued in a private placement, including, without limitation, affirmative
and negative covenants such as information reporting, maintenance of our status
as a BDC within the meaning of the 1940 Act, certain restrictions with respect
to transactions with affiliates, fundamental changes, changes of line of
business, permitted liens, investments and restricted payments, minimum
shareholders' equity, maximum net debt to equity ratio and minimum asset
coverage ratio. The November 2020 NPA also contains customary events of default
with customary cure and notice periods, including, without limitation,
nonpayment, incorrect representation in any material respect, breach of
covenant, cross-default under our other indebtedness or that of our subsidiary
guarantors, certain judgements and orders, and certain events of bankruptcy.
Upon the occurrence of an event of default, the holders of at least 66-2/3% in
principal amount of the November Notes at the time outstanding may declare all
November Notes then outstanding to be immediately due and payable. As of
March 31, 2022, we were in compliance with all covenants under the November 2020
NPA.

The November Notes were offered in reliance on Section 4(a)(2) of the Securities
Act. The November Notes have not and will not be registered under the Securities
Act or any state securities laws and, unless so registered, may not be offered
or sold in the United States except pursuant to an exemption from, or in a
transaction not subject to, the registration requirements of the Securities Act,
as applicable.

As of March 31, 2022, the fair value of the outstanding Series B Notes and the
Series C Notes was $61.1 million and $109.0 million, respectively. The fair
value determinations of the Series B Notes and Series C Notes were based on a
market yield approach and current interest rates, which are Level 3 inputs to
the market yield model.

February Notes

On February 25, 2021, we entered into a Note Purchase Agreement (the "February
2021 NPA") governing the issuance of (1) $80.0 million in aggregate principal
amount of Series D senior unsecured notes due February 26, 2026 (the "Series D
Notes") with a fixed interest rate of 3.41% per year and (2) $70.0 million in
aggregate principal amount of Series E senior unsecured notes due February 26,
2028 (the "Series E Notes" and, collectively with the Series D Notes, the
"February Notes") with a fixed interest rate of 4.06% per year, in each case, to
qualified institutional investors in a private placement. Each stated interest
rate is subject to a step up of (x) 0.75% per year, to the extent the applicable
February Notes do not satisfy certain investment grade rating conditions and/or
(y) 1.50% per year, to the extent the ratio of our secured debt to total assets
exceeds specified thresholds, measured as of each fiscal quarter end. The
February Notes were delivered and paid for on February 26, 2021.

The Series D Notes will mature on February 26, 2026, and the Series E Notes will
mature on February 26, 2028 unless redeemed, purchased or prepaid prior to such
date by us in accordance with the terms of the February 2021 NPA. Interest on
the February Notes is due semiannually in February and August of each year,
beginning in August 2021. In addition, we are obligated to offer to repay the
February Notes at par (plus accrued and unpaid interest to, but not including,
the date of prepayment) if certain change in control events occur. Subject to
the terms of the February 2021 NPA, we may redeem the Series D Notes and the
Series E Notes in whole or in part at any time or from time to time at our
option at par plus accrued interest to the prepayment date and, if redeemed on
or before August 26, 2025, with respect to the Series D Notes, or on or before
August 26, 2027, with respect to the Series E Notes, a make-whole premium. The
February Notes are guaranteed by certain of our subsidiaries, and are our
general unsecured obligations that rank pari passu with all outstanding and
future unsecured unsubordinated indebtedness issued by us.
                                      102
--------------------------------------------------------------------------------

The February 2021 NPA contains certain representations and warranties, and
various covenants and reporting requirements customary for senior unsecured
notes issued in a private placement, including, without limitation, information
reporting, maintenance of our status as a BDC within the meaning of the 1940
Act, and certain restrictions with respect to transactions with affiliates,
fundamental changes, changes of line of business, permitted liens, investments
and restricted payments. In addition, the February 2021 NPA contains the
following financial covenants: (a) maintaining a minimum obligors' net worth,
measured as of each fiscal quarter end; (b) not permitting our asset coverage
ratio, as of the date of the incurrence of any debt for borrowed money or the
making of any cash dividend to shareholders, to be less than the statutory
minimum then applicable to us under the 1940 Act; and (c) not permitting our net
debt to equity ratio to exceed 2.0x, measured as of each fiscal quarter end.

The February 2021 NPA also contains customary events of default with customary
cure and notice periods, including, without limitation, nonpayment, incorrect
representation in any material respect, breach of covenant, cross-default under
other indebtedness or that of our subsidiary guarantors, certain judgements and
orders, and certain events of bankruptcy. Upon the occurrence of certain events
of default, the holders of at least 66-2/3% in principal amount of the February
Notes at the time outstanding may declare all February Notes then outstanding to
be immediately due and payable. As of March 31, 2022, we were in compliance with
all covenants under the February 2021 NPA.

The February Notes were offered in reliance on Section 4(a)(2) of the Securities
Act. The February Notes have not and will not be registered under the Securities
Act or any state securities laws and, unless so registered, may not be offered
or sold in the United States except pursuant to an exemption from, or in a
transaction not subject to, the registration requirements of the Securities Act,
as applicable.

As of March 31, 2022, the fair value of the outstanding Series D Notes and the
Series E Notes was $75.5 million and $65.2 million, respectively. The fair value
determinations of the Series D Notes and Series E Notes were based on a market
yield approach and current interest rates, which are Level 3 inputs to the
market yield model.

November 2026 Notes



On November 23, 2021, we entered into an Indenture (the "Base Indenture") and a
Supplemental Indenture (the "First Supplemental Indenture" and, together with
the Base Indenture, the "Indenture") with U.S. Bank National Association (the
"Trustee"). The First Supplemental Indenture relates to our issuance of $350.0
million aggregate principal amount of its 3.300% notes due 2026 (the "November
2026 Notes").

The November 2026 Notes will mature on November 23, 2026 and may be redeemed in
whole or in part at our option at any time or from time to time at the
redemption prices set forth in the Indenture. The November 2026 Notes bear
interest at a rate of 3.300% per year payable semi-annually on May 23 and
November 23 of each year, commencing on May 23, 2022. The November 2026 Notes
are our general unsecured obligations that rank senior in right of payment to
all of our existing and future indebtedness that is expressly subordinated in
right of payment to the November 2026 Notes, rank pari passu with all existing
and future unsecured unsubordinated indebtedness issued by us, rank effectively
junior to any of our secured indebtedness (including unsecured indebtedness that
we later secure) to the extent of the value of the assets securing such
indebtedness, and rank structurally junior to all existing and future
indebtedness (including trade payables) incurred by our subsidiaries, financing
vehicles or similar facilities.

The Indenture contains certain covenants, including covenants requiring us to
comply with the asset coverage requirements of Section 18(a)(1)(A) as modified
by Section 61(a)(1) and (2) of the 1940 Act, whether or not it is subject to
those requirements, and to provide financial information to the holders of the
November 2026 Notes and the Trustee if we are no longer subject to the reporting
requirements under the Exchange Act. These covenants are subject to important
limitations and exceptions that are described in the Indenture.

In addition, on the occurrence of a "change of control repurchase event," as
defined in the Indenture, we will generally be required to make an offer to
purchase the outstanding November 2026 Notes at a price equal to 100% of the
principal amount of such November 2026 Notes plus accrued and unpaid interest to
the repurchase date.

The November 2026 Notes were offered to persons reasonably believed to be
qualified institutional buyers pursuant to Rule 144A under the Securities Act
and to certain non-U.S. persons outside the United States pursuant to Regulation
S under the Securities Act. The November 2026 Notes have not been registered
under the Securities Act or any state securities laws and may not be offered or
sold in the United States absent registration or an applicable exemption from
such registration requirements.
                                      103
--------------------------------------------------------------------------------

As of March 31, 2022, the fair value of the outstanding November 2026 Notes was
$320.9 million. The fair value determinations of the November 2026 Notes were
based on a market yield approach and current interest rates, which are Level 3
inputs to the market yield model.

Share Repurchases



In connection with the closing of the MVC Acquisition on December 23, 2020, we
committed to make open-market purchases of shares of our common stock in an
aggregate amount of up to $15.0 million at then-current market prices at any
time shares trade below 90% of our then most recently disclosed NAV per share.
Any repurchases pursuant to the authorized program will occur during the
12-month period that commenced upon the filing of our quarterly report on Form
10-Q for the quarter ended March 31, 2021, which occurred on May 6, 2021, and
will be made in accordance with applicable legal, contractual and regulatory
requirements. During the three months ended March 31, 2022, we repurchased a
total of 207,677 shares of our common stock in the open market under the
authorized program at an average price of $10.14 per share, including broker
commissions.

In connection with the completion of the acquisition of Sierra, we committed to
make open-market purchases of shares of our common stock in an aggregate amount
of up to $30.0 million at then-current market prices at any time shares trade
below 90% of our then most recently disclosed NAV per share. Any repurchases
pursuant to the authorized program will occur during the 12-month period
commencing on April 1, 2022 and are expected to be made in accordance with a
Rule 10b5-1 purchase plan that qualifies for the safe harbors provided by Rules
10b5-1 and 10b-18 under the Exchange Act, as well as subject to compliance with
our covenant and regulatory requirements.

Distributions to Stockholders



We intend to pay quarterly distributions to our stockholders out of assets
legally available for distribution. We have adopted a dividend reinvestment plan
("DRIP") that provides for reinvestment of dividends on behalf of our
stockholders, unless a stockholder elects to receive cash. As a result, when we
declare a dividend, stockholders who have not opted out of the DRIP will have
their dividends automatically reinvested in shares of our common stock, rather
than receiving cash dividends.

We have elected to be treated as a RIC under the Code, and intend to make the
required distributions to our stockholders as specified therein. In order to
maintain our tax treatment as a RIC and to obtain RIC tax benefits, we must meet
certain minimum distribution, source-of-income and asset diversification
requirements. If such requirements are met, then we are generally required to
pay income taxes only on the portion of our taxable income and gains we do not
distribute (actually or constructively) and certain built-in gains. We have
historically met our minimum distribution requirements and continually monitor
our distribution requirements with the goal of ensuring compliance with the
Code. We can offer no assurance that we will achieve results that will permit
the payment of any level of cash distributions and our ability to make
distributions will be limited by the asset coverage requirement and related
provisions under the 1940 Act and contained in any applicable indenture or
financing agreement and related supplements. In addition, in order to satisfy
the annual distribution requirement applicable to RICs, we may declare a
significant portion of our dividends in shares of our common stock instead of in
cash. As long as a portion of such dividend is paid in cash (which portion may
be as low as 20% of such dividend (and 10% of the dividend declared through June
30, 2022) under published guidance from the Internal Revenue Service) and
certain requirements are met, the entire distribution will be treated as a
dividend for U.S. federal income tax purposes. As a result, a stockholder
generally would be subject to tax on 100% of the fair market value of the
dividend on the date the dividend is received by the stockholder in the same
manner as a cash dividend, even though most of the dividend was paid in shares
of our common stock.

The minimum distribution requirements applicable to RICs require us to
distribute to our stockholders each year at least 90% of our investment company
taxable income, or ICTI, as defined by the Code. Depending on the level of ICTI
and net capital gain, if any, earned in a tax year, we may choose to carry
forward ICTI in excess of current year distributions into the next tax year and
pay a 4% U.S. federal excise tax on such excess. Any such carryover ICTI must be
distributed before the end of the next tax year through a dividend declared
prior to filing the final tax return related to the year which generated such
ICTI.

ICTI generally differs from net investment income for financial reporting
purposes due to temporary and permanent differences in the recognition of income
and expenses. We may be required to recognize ICTI in certain circumstances in
which we do not receive cash. For example, if we hold debt obligations that are
treated under applicable tax rules as having original issue discount (such as
debt instruments issued with warrants), we must include in ICTI each year a
portion of the original issue discount that accrues over the life of the
obligation, regardless of whether cash representing such income is received by
us in the same taxable year. We may also have to include in ICTI other amounts
that we have not yet received in cash, such as (i) PIK interest income and (ii)
interest income from investments that have been classified as non-accrual for
financial reporting purposes. Interest income on non-accrual investments is not
recognized for financial reporting purposes, but generally is recognized in
ICTI. Because any original issue discount or other amounts accrued will be
included in our ICTI for the year of
                                      104
--------------------------------------------------------------------------------

accrual, we may be required to make a distribution to our stockholders in order
to satisfy the minimum distribution requirements, even though we will not have
received and may not ever receive any corresponding cash amount. ICTI also
excludes net unrealized appreciation or depreciation, as investment gains or
losses are not included in taxable income until they are realized.

Recent Developments



Subsequent to March 31, 2022, we made approximately made approximately $174.4
million of new commitments, of which $141.0 million closed and funded. The
$141.0 million of investments consists of $120.9 million of first lien senior
secured debt investments, $16.2 million of second lien senior secured and
subordinated debt investments and $3.8 million of equity investments. The
weighted average yield of the debt investments was 7.1%. In addition, the
Company funded $15.0 million of previously committed delayed draw term loans.

Effective on April 1, 2022, we increased aggregate commitments under the
February 2019 Credit Facility to $1.1 billion from $965.0 million pursuant to
the accordion feature under the February 2019 Credit Facility, which allows for
an increase in the total commitments to an aggregate of $1.5 billion subject to
certain conditions and the satisfaction of specified financial covenants.

On May 5, 2022, the Board declared a quarterly distribution of $0.24 per share payable on June 15, 2022 to holders of record as of June 8, 2022.

Critical Accounting Policies and Use of Estimates



The preparation of our unaudited financial statements in accordance with U.S.
GAAP requires management to make certain estimates and assumptions that affect
the reported amounts of assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses for the periods
covered by such financial statements. We have identified investment valuation
and revenue recognition as our most critical accounting estimates. On an ongoing
basis, we evaluate our estimates, including those related to the matters
described below. These estimates are based on the information that is currently
available to us and on various other assumptions that we believe to be
reasonable under the circumstances. Actual results could differ materially from
those estimates under different assumptions or conditions. A discussion of our
critical accounting policies follows.

Investment Valuation



The most significant estimate inherent in the preparation of our financial
statements is the valuation of investments and the related amounts of unrealized
appreciation and depreciation of investments recorded. We have a valuation
policy, as well as established and documented processes and methodologies for
determining the fair values of portfolio company investments on a recurring (at
least quarterly) basis in accordance with the 1940 Act and FASB ASC Topic 820,
Fair Value Measurements and Disclosures, or ASC Topic 820. Our current valuation
policy and processes were established by Barings and have been approved by the
Board.

As of March 31, 2022, our investment portfolio, valued at fair value in
accordance with the Board-approved valuation policies, represented approximately
182% of our total net assets, as compared to approximately 243% of our total net
assets as of December 31, 2021.

Under ASC Topic 820, fair value is the price that would be received to sell an
asset or paid to transfer a liability in an orderly transaction between a
willing buyer and a willing seller at the measurement date. For our portfolio
securities, fair value is generally the amount that we might reasonably expect
to receive upon the current sale of the security. The fair value measurement
assumes that the sale occurs in the principal market for the security, or in the
absence of a principal market, in the most advantageous market for the security.
If no market for the security exists or if we do not have access to the
principal market, the security should be valued based on the sale occurring in a
hypothetical market.

Under ASC Topic 820, there are three levels of valuation inputs, as follows:

Level 1 Inputs - include quoted prices (unadjusted) in active markets for identical assets or liabilities.



Level 2 Inputs - include quoted prices for similar assets and liabilities in
active markets, and inputs that are observable for the asset or liability,
either directly or indirectly, for substantially the full term of the financial
instrument.

Level 3 Inputs - include inputs that are unobservable and significant to the fair value measurement.


                                      105
--------------------------------------------------------------------------------

A financial instrument is categorized within the ASC Topic 820 valuation
hierarchy based upon the lowest level of input to the valuation process that is
significant to the fair value measurement. For example, a Level 3 fair value
measurement may include inputs that are observable (Levels 1 and 2) and
unobservable (Level 3). Therefore, unrealized appreciation and depreciation
related to such investments categorized as Level 3 investments within the tables
in the notes to our consolidated financial statements may include changes in
fair value that are attributable to both observable inputs (Levels 1 and 2) and
unobservable inputs (Level 3).

Our investment portfolio includes certain debt and equity instruments of
privately held companies for which quoted prices or other observable inputs
falling within the categories of Level 1 and Level 2 are generally not
available. In such cases, we determine the fair value of our investments in good
faith primarily using Level 3 inputs. In certain cases, quoted prices or other
observable inputs exist, and if so, we assess the appropriateness of the use of
these third-party quotes in determining fair value based on (i) our
understanding of the level of actual transactions used by the broker to develop
the quote and whether the quote was an indicative price or binding offer and
(ii) the depth and consistency of broker quotes and the correlation of changes
in broker quotes with underlying performance of the portfolio company.

There is no single standard for determining fair value in good faith, as fair
value depends upon the specific circumstances of each individual investment. The
recorded fair values of our Level 3 investments may differ significantly from
fair values that would have been used had an active market for the securities
existed. In addition, changes in the market environment and other events that
may occur over the life of the investments may cause the gains or losses
ultimately realized on these investments to be different than the valuations
currently assigned.

Investment Valuation Process

Barings has established a pricing committee that is, subject to the oversight of
the Board, responsible for the approval, implementation and oversight of the
processes and methodologies that relate to the pricing and valuation of assets
we hold. Barings uses independent third-party providers to price the portfolio,
but in the event an acceptable price cannot be obtained from an approved
external source, Barings will utilize alternative methods in accordance with
internal pricing procedures established by Barings' pricing committee.

At least annually, Barings conducts reviews of the primary pricing vendors to
validate that the inputs used in the vendors' pricing process are deemed to be
market observable. While Barings is not provided access to proprietary models of
the vendors, the reviews have included on-site walkthroughs of the pricing
process, methodologies and control procedures for each asset class and level for
which prices are provided. The review also includes an examination of the
underlying inputs and assumptions for a sample of individual securities across
asset classes, credit rating levels and various durations, a process Barings
continues to perform annually. In addition, the pricing vendors have an
established challenge process in place for all security valuations, which
facilitates identification and resolution of prices that fall outside expected
ranges. Barings believes that the prices received from the pricing vendors are
representative of prices that would be received to sell the assets at the
measurement date (i.e., exit prices).

Our money market fund investments are generally valued using Level 1 inputs and
our equity investments listed on an exchange or on the NASDAQ National Market
System are valued using Level 1 inputs, using the last quoted sale price of that
day. Our syndicated senior secured loans and structured product investments are
generally valued using Level 2 inputs, which are generally valued at the bid
quotation obtained from dealers in loans by an independent pricing service. Our
middle-market, private debt and equity investments are generally valued using
Level 3 inputs.

Independent Valuation

The fair value of loans and equity investments that are not syndicated or for
which market quotations are not readily available, including middle-market
loans, are generally submitted to independent providers to perform an
independent valuation on those loans and equity investments as of the end of
each quarter. Such loans and equity investments are initially held at cost, as
that is a reasonable approximation of fair value on the acquisition date, and
monitored for material changes that could affect the valuation (for example,
changes in interest rates or the credit quality of the borrower). At the quarter
end following the initial acquisition, such loans and equity investments are
generally sent to a valuation provider which will determine the fair value of
each investment. The independent valuation providers apply various methods
(synthetic rating analysis, discounting cash flows, and re-underwriting
analysis) to establish the rate of return a market participant would require
(the "discount rate") as of the valuation date, given market conditions,
prevailing lending standards and the perceived credit quality of the issuer.
Future expected cash flows for each investment are discounted back to present
value using these discount rates in the discounted cash flow analysis. A range
of values will be provided by the valuation provider and Barings will determine
the point within that range that it will use in making valuation recommendations
to the Board, and will report to the Board on its rationale for each such
determination. Barings uses its internal valuation model as a comparison point
to validate the price range
                                      106
--------------------------------------------------------------------------------

provided by the valuation provider and, where applicable, in determining the
point within that range that it will use in making valuation recommendations to
the Board. If Barings' pricing committee disagrees with the price range
provided, it may make a fair value recommendation to the Board that is outside
of the range provided by the independent valuation provider, and will notify the
Board of any such override and the reasons therefore. In certain instances, we
may determine that it is not cost-effective, and as a result is not in the
stockholders' best interests, to request an independent valuation firm to
perform an independent valuation on certain investments. Such instances include,
but are not limited to, situations where the fair value of the investment in the
portfolio company is determined to be insignificant relative to the total
investment portfolio. Pursuant to these procedures, the Board determines in good
faith whether our investments were valued at fair value in accordance with our
valuation policies and procedures and the 1940 Act based on, among other things,
the input of Barings, our Audit Committee and the independent valuation firm.

The SEC has adopted new Rule 2a-5 under the 1940 Act. This rule establishes
requirements for determining fair value in good faith for purposes of the 1940
Act. We will comply with the new rule's valuation requirements on or before the
SEC's September 8, 2022 compliance date.

Valuation Techniques



Our valuation techniques are based upon both observable and unobservable pricing
inputs. Observable inputs reflect market data obtained from independent sources,
while unobservable inputs reflect our market assumptions. Our assessment of the
significance of a particular input to the fair value measurement in its entirety
requires judgment and considers factors specific to the financial instrument. An
independent pricing service provider is the preferred source of pricing a loan,
however, to the extent the independent pricing service provider price is
unavailable or not relevant and reliable, we will utilize alternative approaches
such as broker quotes or manual prices. We attempt to maximize the use of
observable inputs and minimize the use of unobservable inputs. The availability
of observable inputs can vary from investment to investment and is affected by a
wide variety of factors, including the type of security, whether the security is
new and not yet established in the marketplace, the liquidity of markets and
other characteristics particular to the security.

Valuation of Investments in Jocassee, Thompson Rivers, Waccamaw River, Sierra JV and MVC Private Equity Fund LP



As Jocassee, Thompson Rivers, Waccamaw River, Sierra JV and MVC Private Equity
Fund LP are investment companies with no readily determinable fair values, we
estimate the fair value of our investments in these entities using net asset
value of each company and our ownership percentage as a practical expedient. The
net asset value is determined in accordance with the specialized accounting
guidance for investment companies.

Revenue Recognition

Interest and Dividend Income



Interest income, including amortization of premium and accretion of discount, is
recorded on the accrual basis to the extent that such amounts are expected to be
collected. Generally, when interest and/or principal payments on a loan become
past due, or if we otherwise do not expect the borrower to be able to service
its debt and other obligations, we will place the loan on non-accrual status and
will generally cease recognizing interest income on that loan for financial
reporting purposes until all principal and interest have been brought current
through payment or due to a restructuring such that the interest income is
deemed to be collectible. The cessation of recognition of such interest will
negatively impact the reported fair value of the investment. We write off any
previously accrued and uncollected interest when it is determined that interest
is no longer considered collectible. Dividend income is recorded on the
ex-dividend date.

We may have to include interest income in our ICTI, including original issue
discount income, from investments that have been classified as non-accrual for
financial reporting purposes. Interest income on non-accrual investments is not
recognized for financial reporting purposes, but generally is recognized in
ICTI. As a result, we may be required to make a distribution to our stockholders
in order to satisfy the minimum distribution requirements to maintain our RIC
tax treatment, even though we will not have received and may not ever receive
any corresponding cash amount. Additionally, any loss recognized by us for U.S.
federal income tax purposes on previously accrued interest income will be
treated as a capital loss.

Fee Income



Origination, facility, commitment, consent and other advance fees received in
connection with the origination of a loan, or Loan Origination Fees, are
recorded as deferred income and recognized as investment income over the term of
the loan. Upon prepayment of a loan, any unamortized Loan Origination Fees are
recorded as investment income. In the general course of our business, we receive
certain fees from portfolio companies, which are non-recurring in nature. Such
fees include loan prepayment penalties, advisory, loan amendment and other fees,
and are recorded as investment income when earned.
                                      107
--------------------------------------------------------------------------------

Fee income for the three months ended March 31, 2022 and 2021 was as follows:

                                                        Three Months        Three Months
                                                           Ended               Ended
($ in thousands)                                       March 31, 2022      March 31, 2021
Recurring Fee Income:
Amortization of loan origination fees                 $        1,327      $ 

1,078


Management, valuation and other fees                            (585)                581
Total Recurring Fee Income                                       742               1,659
Non-Recurring Fee Income:
Prepayment fees                                                    -                  50
Acceleration of unamortized loan origination fees                196        

403


Advisory, loan amendment and other fees                          259        

21


Total Non-Recurring Fee Income                                   455                 474
Total Fee Income                                      $        1,197      $        2,133

Payment-in-Kind (PIK) Interest Income



We currently hold, and expect to hold in the future, some loans in our portfolio
that contain PIK interest provisions. PIK interest, computed at the contractual
rate specified in each loan agreement, is periodically added to the principal
balance of the loan, rather than being paid to us in cash, and is recorded as
interest income. Thus, the actual collection of PIK interest may be deferred
until the time of debt principal repayment.

PIK interest, which is a non-cash source of income at the time of recognition,
is included in our taxable income and therefore affects the amount we are
required to distribute to our stockholders to maintain our tax treatment as a
RIC for U.S. federal income tax purposes, even though we have not yet collected
the cash. Generally, when current cash interest and/or principal payments on a
loan become past due, or if we otherwise do not expect the borrower to be able
to service its debt and other obligations, we will place the loan on non-accrual
status and will generally cease recognizing PIK interest income on that loan for
financial reporting purposes until all principal and interest have been brought
current through payment or due to a restructuring such that the interest income
is deemed to be collectible. We write off any previously accrued and uncollected
PIK interest when it is determined that the PIK interest is no longer
collectible.

We may have to include in our ICTI, PIK interest income from investments that
have been classified as non-accrual for financial reporting purposes. Interest
income on non-accrual investments is not recognized for financial reporting
purposes, but generally is recognized in ICTI. As a result, we may be required
to make a distribution to our stockholders in order to satisfy the minimum
distribution requirements, even though we will not have received and may not
ever receive any corresponding cash amount.

Unused Commitments



In the normal course of business, we are party to financial instruments with
off-balance sheet risk, consisting primarily of unused commitments to extend
financing to our portfolio companies. Since commitments may expire without being
drawn upon, the total commitment amount does not necessarily represent future
cash requirements. As of March 31, 2022 and December 31, 2021, we believed that
we had adequate financial resources to satisfy our unfunded commitments. The
balances of unused commitments to extend financing as of March 31, 2022 and
December 31, 2021 were as follows:

Portfolio Company
($ in thousands)                          Investment Type                       March 31, 2022           December 31, 2021
1888 Industrial Services, LLC(1)(2)       Revolver                            $           314          $                -
Acclime Holdings HK Limited(1)            Delayed Draw Term Loan                        1,179                       1,179
Acclime Holdings HK Limited(1)            Delayed Draw Term Loan                          110                         110
Air Comm Corporation, LLC(1)              Delayed Draw Term Loan                           11                          11
Air Comm Corporation, LLC(1)              Delayed Draw Term Loan                        1,448                       1,448
Amtech Software(1)                        Delayed Draw Term Loan                        1,527                       2,727
Amtech Software(1)                        Revolver                                        682                         682


                                      108

--------------------------------------------------------------------------------

Portfolio Company
($ in thousands)                             Investment Type                         March 31, 2022              December 31, 2021
AnalytiChem Holding GmbH(1)(2)(3)            Delayed Draw Term Loan                        6,073                         6,207
Aquavista Watersides 2 LTD(1)(2)(4)          Bridge Revolver                                 489                           503

Aquavista Watersides 2 LTD(1)(2)(4) Acquisition Facility

                3,059                         3,147
Astra Bidco Limited(1)(2)(4)                 Delayed Draw Term Loan                          959                         2,571

Avance Clinical Bidco Pty Ltd(1)(5) Delayed Draw Term Loan


               1,435                         3,497
Azalea Buyer, Inc.(1)                        Delayed Draw Term Loan                          962                           962
Azalea Buyer, Inc.(1)                        Revolver                                        481                           481
Bariacum S.A(1)(2)(3)                        Acquisition Facility                          2,114                         2,161
Beyond Risk Management, Inc.(1)(2)           Delayed Draw Term Loan                        2,573                         2,573
BigHand UK Bidco Limited(1)(2)(4)            Acquisition Facility                              -                           378
Black Angus Steakhouses, LLC(1)              Acquisition Facility                            417                             -
Bounteous, Inc.(1)                           Delayed Draw Term Loan                        2,840                         2,840
Brightpay Limited(1)(2)(3)                   Delayed Draw Term Loan                          241                           432
Brightpay Limited(1)(2)(3)                   Delayed Draw Term Loan                          141                           144
BrightSign LLC(1)                            Revolver                                      1,329                         1,329
British Engineering Services Holdco
Limited(1)(2)(4)                             Bridge Revolver                                   -                           613
Brook & Whittle Holding Corp.(1)             Delayed Draw Term Loan                          852                             -
CAi Software, LLC(1)                         Revolver                                        943                           943

Canadian Orthodontic Partners Corp.(1)(2)(6) Acquisition Facility

                  120                           167
Centralis Finco S.a.r.l.(1)(3)               Acquisition Facility                            451                           461
Ceres Pharma NV(1)(2)(3)                     Delayed Draw Term Loan                        2,103                         2,149
CGI Parent, LLC(1)(2)                        Revolver                                      1,212                             -

Classic Collision (Summit Buyer, LLC)(1)(2) Delayed Draw Term Loan

                  309                           393
Coastal Marina Holdings, LLC(1)(2)           PIK Tranche B Term Loan                       1,311                         1,311
Coastal Marina Holdings, LLC(1)(2)           Tranche A Term Loan                           3,576                         3,576

Command Alkon (Project Potter Buyer, LLC)(1) Delayed Draw Term Loan


               6,018                         6,018
Coyo Uprising GmbH(1)(2)(3)                  Delayed Draw Term Loan                          874                           894
Crash Champions, LLC(1)                      Delayed Draw Term Loan                          379                         5,420
CSL Dualcom(1)(4)                            Acquisition Term Loan                           970                           998
Dart Buyer, Inc.(1)                          Delayed Draw Term Loan                        1,163                         2,431
DecksDirect, LLC(1)                          Revolver                                         58                           218
DreamStart Bidco SAS(1)(3)                   Acquisition Facility                            604                           617
Dune Group(1)(3)                             Delayed Draw Term Loan                          650                           665
Dwyer Instruments, Inc.(1)                   Delayed Draw Term Loan                          692                           692
Eclipse Business Capital, LLC(1)             Revolver                                     10,909                        11,818
EMI Porta Holdco LLC(1)                      Delayed Draw Term Loan                       11,212                        12,458
EMI Porta Holdco LLC(1)                      Revolver                                      2,361                         2,966
EPS NASS Parent, Inc.(1)                     Delayed Draw Term Loan                          583                           583
eShipping, LLC(1)                            Delayed Draw Term Loan                        1,650                         2,548
eShipping, LLC(1)                            Revolver                                        824                         1,232

Events Software BidCo Pty Ltd(1)(5) Delayed Draw Term Loan

                  481                             -
F24 (Stairway BidCo GmbH)(1)(2)(3)           Delayed Draw Term Loan                          396                           405
Fineline Technologies, Inc.(1)               Delayed Draw Term Loan                          180                           180
Finexvet(1)(3)                               Acquisition Facility                            967                             -
FragilePak LLC(1)(2)                         Delayed Draw Term Loan                        2,354                         2,354

Heartland Veterinary Partners, LLC(1) Delayed Draw Term Loan

                  657                           657


                                      109
--------------------------------------------------------------------------------

Portfolio Company
($ in thousands)                                  Investment Type                     March 31, 2022              December 31, 2021
Heavy Construction Systems Specialists, LLC(1)    Revolver                                  2,632                         2,632
HW Holdco, LLC (Hanley Wood LLC)(1)(2)            Delayed Draw Term Loan                      913                         1,563
IGL Holdings III Corp.(1)                         Delayed Draw Term Loan                    1,217                         1,217
Innovad Group II BV(1)(2)(3)                      Delayed Draw Term Loan                    1,785                         1,825
INOS 19-090 GmbH(1)(2)(3)                         Acquisition Facility                      2,481                         2,535
ITI Intermodal, Inc.(1)                           Delayed Draw Term Loan                      103                           103
ITI Intermodal, Inc.(1)                           Revolver                                    124                           124
Jaguar Merger Sub Inc.(1)(2)                      Delayed Draw Term Loan                    1,781                         1,961
Jaguar Merger Sub Inc.(1)(2)                      Revolver                                    490                           490
Jocassee Partners LLC                             Joint Venture                            15,000                        20,000
Jon Bidco Limited(1)(2)(7)                        Capex & Acquisition Facility              1,585                             -
Jones Fish Hatcheries & Distributors LLC(1)       Revolver                                    418                             -
Kano Laboratories LLC(1)(2)                       Delayed Draw Term Loan                      153                           153
Kano Laboratories LLC(1)(2)                       Delayed Draw Term Loan                    2,830                         4,544
Kemmerer Operations LLC(1)                        Delayed Draw Term Loan                      908                             -
LAF International(1)(2)(3)                        Acquisition Facility                        178                           341
Lambir Bidco Limited(1)(2)(3)                     Bridge Revolver                             920                           941
Lambir Bidco Limited(1)(2)(3)                     Delayed Draw Term Loan                    1,841                         1,881
LeadsOnline, LLC(1)                               Revolver                                  2,603                             -
Lifestyle Intermediate II, LLC(1)                 Revolver                                  2,500                             -
LivTech Purchaser, Inc.(1)                        Delayed Draw Term Loan                       34                            82
Marmoutier Holding B.V.(1)(2)(3)                  Delayed Draw Term Loan                      396                           405
Marmoutier Holding B.V.(1)(2)(3)                  Revolver                                    159                           162
Marshall Excelsior Co.(1)(2)                      Revolver                                  1,047                             -
MC Group Ventures Corporation(1)                  Delayed Draw Term Loan                      817                           817

Modern Star Holdings Bidco Pty Limited(1)(5) Capex Term Loan

                 1,072                         1,038
Murphy Midco Limited(1)(4)                        Delayed Draw Term Loan                      648                         2,617
Narda Acquisitionco., Inc.(1)                     Revolver                                  1,311                         1,311
Navia Benefit Solutions, Inc.(1)                  Delayed Draw Term Loan                    1,261                         1,261
Nexus Underwriting Management Limited(1)(2)(4)    Revolver                                    101                           103

Nexus Underwriting Management Limited(1)(2)(4) Acquisition Facility

                   526                           541
Novotech Aus Bidco Pty Ltd(1)                     Capex & Acquisition Facility                809                             -
OA Buyer, Inc.(1)                                 Revolver                                  1,331                         1,331
OAC Holdings I Corp(1)                            Revolver                                    685                             -
OG III B.V.(1)(2)(3)                              Acquisition CapEx Facility                  671                           686
Omni Intermediate Holdings, LLC(1)(2)             Delayed Draw Term Loan                        -                           817
Omni Intermediate Holdings, LLC(1)(2)             Delayed Draw Term Loan                    2,289                         4,357
OSP Hamilton Purchaser, LLC(1)                    Revolver                                    187                           187
Pacific Health Supplies Bidco Pty
Limited(1)(2)(5)                                  CapEx Term Loan                           1,325                         1,283
PDQ.Com Corporation(1)                            Delayed Draw Term Loan                        -                           289
PDQ.Com Corporation(1)                            Delayed Draw Term Loan                    7,753                        10,948
Polara Enterprises, L.L.C.(1)(2)                  Revolver                                    545                           545
Policy Services Company, LLC(1)(2)                Delayed Draw Term Loan                    3,772                         6,944
Premium Invest(1)(2)(3)                           Acquisition Facility                      1,892                         1,933
ProfitOptics, LLC(1)                              Revolver                                    484                             -
Protego Bidco B.V.(1)(2)(3)                       Delayed Draw Term Loan                      826                           844
QPE7 SPV1 BidCo Pty Ltd(1)(2)(5)                  Acquisition Term Loan                         -                           373


                                      110
--------------------------------------------------------------------------------


Portfolio Company                                                                                      December 31,
($ in thousands)                             Investment Type                   March 31, 2022              2021
RA Outdoors, LLC(1)                          Revolver                                    741                     -
Rep Seko Merger Sub LLC(1)                   Delayed Draw Term Loan                    1,305                 1,455
Reward Gateway (UK) Ltd(1)(2)(4)             Acquisition Facility                        657                 1,061
Riedel Beheer B.V.(1)(2)(3)                  Revolver                                      -                   230
Riedel Beheer B.V.(1)(2)(3)                  Delayed Draw Term Loan                      150                   153
Scaled Agile, Inc.(1)(2)                     Delayed Draw Term Loan                      416                   416
Scaled Agile, Inc.(1)(2)                     Revolver                                    336                   336
Security Holdings B.V.(1)(2)(3)              Delayed Draw Term Loan                    2,225                 2,274
Security Holdings B.V.(1)(2)(3)              Revolver                                  1,113                 1,137
Smartling, Inc.(1)                           Delayed Draw Term Loan                    1,978                 2,353
Smartling, Inc.(1)                           Revolver                                  1,176                 1,176
Smile Brands Group, Inc.(1)(2)               Delayed Draw Term Loan                      418                   655
Springbrook Software (SBRK Intermediate,
Inc.)(1)(2)                                  Delayed Draw Term Loan                    2,372                 2,373
SSCP Pegasus Midco Limited(1)(4)             Delayed Draw Term Loan                    5,105                 5,251
Superjet Buyer, LLC(1)                       Revolver                                  1,825                 1,825
Syntax Systems Ltd(1)(2)                     Revolver                                    448                   569
Syntax Systems Ltd(1)(2)                     Delayed Draw Term Loan                    1,933                 1,933
Tank Holding Corp(1)                         Revolver                                    873                     -
Techone B.V.(1)(2)(3)                        Delayed Draw Term Loan                    1,586                 1,621
Techone B.V.(1)(2)(3)                        Revolver                                    423                   432
Tencarva Machinery Company, LLC(1)           Delayed Draw Term Loan                      886                   886
Tencarva Machinery Company, LLC(1)           Revolver                                  1,128                 1,129
The Caprock Group, Inc. (aka TA/TCG
Holdings, LLC)(1)                            Delayed Draw Term Loan                    2,811                 2,811
The Caprock Group, Inc. (aka TA/TCG
Holdings, LLC)(1)                            Revolver                                    827                   827
The Hilb Group, LLC(1)                       Delayed Draw Term Loan                    2,529                 2,773
Thermacell Repellents, Inc.(1)               Revolver                                    605                     -
Transit Technologies LLC(1)(2)               Delayed Draw Term Loan                        -                 1,857
Truck-Lite Co., LLC(1)                       Delayed Draw Term Loan                    4,540                 4,540
Turbo Buyer, Inc.(1)                         Delayed Draw Term Loan                    1,339                 2,070
Turbo Buyer, Inc.(1)                         Delayed Draw Term Loan                    2,250                     -
USLS Acquisition, Inc.(f/k/a US Legal
Support, Inc.)(1)(2)                         Delayed Draw Term Loan                    3,820                     -
Victoria Bidco Limited(1)(2)(4)              Delayed Draw Term Loan                      458                     -
Waccamaw River, LLC(2)                       Joint Venture                             4,580                11,280
W2O Holdings, Inc.(1)                        Delayed Draw Term Loan                    3,831                 3,832
West Dermatology, LLC(1)                     Revolver                                    552                     -
West Dermatology, LLC(1)                     Delayed Draw Term Loan                    3,352                     -
West Dermatology, LLC(1)                     PIK Delayed Draw Term Loan                  144                     -
Woodland Foods, Inc.(1)                      Revolver                                  1,734                 2,070
ZB Holdco LLC(1)                             Revolver                                    845                     -
ZB Holdco LLC(1)                             Delayed Draw Term Loan                    1,352                     -
Zeppelin Bidco Limited(1)(2)(4)              Capex / Acquisition Facility              3,472                     -
Zeppelin Bidco Limited(1)(2)(4)              Revolver                        $           579          $          -
Total unused commitments to extend financing                                

$ 220,360 $ 234,658




(1)Our estimate of the fair value of the current investments in these portfolio
companies includes an analysis of the fair value of any unfunded commitments.
(2)Represents a commitment to extend financing to a portfolio company where one
or more of our current investments in the portfolio company are carried at less
than cost.
(3)Actual commitment amount is denominated in Euros. Commitment was translated
into U.S. dollars based on the spot rate at the relevant balance sheet date.
                                      111

--------------------------------------------------------------------------------



(4)Actual commitment amount is denominated in British pounds sterling.
Commitment was translated into U.S. dollars based on the spot rate at the
relevant balance sheet date.
(5)Actual commitment amount is denominated in Australian dollars. Commitment was
translated into U.S. dollars based on the spot rate at the relevant balance
sheet date.
(6)Actual commitment amount is denominated in Canadian dollars. Commitment was
translated into U.S. dollars based on the spot rate at the relevant balance
sheet date.
(7)Actual commitment amount is denominated in New Zealand dollars. Commitment
was translated into U.S. dollars based on the spot rate at the relevant balance
sheet date.

In the normal course of business, we guarantee certain obligations in connection
with our portfolio companies (in particular, certain controlled portfolio
companies). Under these guarantee arrangements, payments may be required to be
made to third parties if such guarantees are called upon or if the portfolio
companies were to default on their related obligations, as applicable. As of
March 31, 2022 and December 31, 2021, we had guaranteed €9.9 million ($11.0
million U.S. dollars and $11.3 million U.S. dollars, respectively) relating to
credit facilities among Erste Bank and MVC Automotive Group Gmbh, or MVC Auto.
We would be required to make payments to Erste Bank if MVC Auto were to default
on their related payment obligations. None of the credit facility guarantees are
recorded as a liability on our Unaudited and Audited Consolidated Balance
Sheets. As such, the credit facility liabilities are considered in the valuation
of our investments in MVC Auto. The guarantees denominated in foreign currencies
were translated into U.S. dollars based on the spot rate at the relevant balance
sheet date.

© Edgar Online, source Glimpses